The NIH Is Going to Discover Drugs... Really? Forbes A JAK inhibitor was hypothesized to be effective in diseases where the immune system is overactive, such as organ transplant rejection, psoriasis, and RA. When a brand new agent has been discovered by a company that has many theoretical uses, ... |
